Volume 19, Number 7—July 2013
Avian Influenza A(H7N9) Virus Infections, Shanghai, China
|Exposure to poultry||None||Continuous||None||None|
|Sign or symptom at admission||Fever (40.6°C) for 7 d, cough for 1 d, difficulty breathing starting 7 d after illness onset||Fever (39.8°C) for 3 d, cough for 5 d, difficulty breathing and cyanosis starting 5 d after illness onset||Fever (39.7°C) and cough for 7 d starting 7 d after illness onset||Fever (39.0°C) for 5 d, cough for 2 d starting 5 d after illness onset|
|Physical examination results||HR 120 bpm, RR 40 breaths/min, BP 140/75 mm Hg, decreased breath sounds, no rales||RR 40 breaths/min, BP 240/160 mm Hg, diffuse moist rales||HR 100 bpm, RR 30 breaths/min, BP 110/78 mm Hg, moist rales mainly in left lung||HR 82 bpm, RR 21 breaths/min, BP 118/74 mm Hg, decreased breath sounds in lower left lung, no rales|
|Leukocyte count, ×109/L||3.29||2.9||2.89||3.74|
|Platelet count, ×109/L||155||71||172||82|
|Medications after hospitalization|
|Oseltamivir||Started d 13 after illness onset||None||Started d 11 after illness onset||Started d 10 after illness onset|
|Antimicrobial drugs||MOX started d 13 after illness onset||MOX started d 10 after illness onset||AZT started d 11 after illness onset, MOX started d 15 after illness onset||CEF started d 11–12 after illness onset, MOX started d 13 after illness onset|
|Corticosteroids||MEP, 80 mg/d started d 14 after illness onset||MEP, 80 mg/d started d 10 after illness onset||MEP, 80 mg/d started d 11 after illness onset, decreased to 40 mg/d, stopped after 1 wk||None|
|Immunoglobulin||Started d 13 after illness onset||None||Given d 11–15 after illness onset||None|
|Other conditions||Diabetes mellitus, surgery for thyroid cancer||Obesity||None||Hypertension|
|Outcome||Died 14 d after illness onset||Died 10 d after illness onset||Discharged 30 d after illness onset||Discharged 27 d after illness onset|
*HR, heart rate; RR, respiratory rate; BP, blood pressure, AST, aspartate aminotransferase; LDH, lactate dehydrogenase; CPK, creatine phosphokinase; CK-MB, creatine kinase isoenzyme MB; MOX, moxifloxacin; AZT, azithromycin; CEF, ceftriaxone; MEP, methylprednisolone.
†Data for patient 1 were reported by Yang et al. (3) and are included for comparison.
1These authors contributed equally to this article.
- Page created: June 19, 2013
- Page last updated: June 19, 2013
- Page last reviewed: June 19, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)